Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bolt Biotherapeutics (BOLT) Interest & Investment Income (2020 - 2025)

Historic Interest & Investment Income for Bolt Biotherapeutics (BOLT) over the last 6 years, with Q3 2025 value amounting to $477000.0.

  • Bolt Biotherapeutics' Interest & Investment Income fell 6235.2% to $477000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 4934.83%. This contributed to the annual value of $5.3 million for FY2024, which is 2491.78% down from last year.
  • Per Bolt Biotherapeutics' latest filing, its Interest & Investment Income stood at $477000.0 for Q3 2025, which was down 6235.2% from $599000.0 recorded in Q2 2025.
  • In the past 5 years, Bolt Biotherapeutics' Interest & Investment Income ranged from a high of $1.9 million in Q3 2023 and a low of -$82000.0 during Q4 2021
  • Its 5-year average for Interest & Investment Income is $935055.6, with a median of $1.0 million in 2022.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first tumbled by 78333.33% in 2021, then skyrocketed by 137195.12% in 2022.
  • Bolt Biotherapeutics' Interest & Investment Income (Quarter) stood at -$82000.0 in 2021, then skyrocketed by 1371.95% to $1.0 million in 2022, then soared by 78.62% to $1.9 million in 2023, then tumbled by 47.4% to $980000.0 in 2024, then tumbled by 51.33% to $477000.0 in 2025.
  • Its last three reported values are $477000.0 in Q3 2025, $599000.0 for Q2 2025, and $1.1 million during Q1 2025.